نتائج البحث

Analytical Methods for Estimating Metformin Hydrochloride, Pioglitazone and Teneligliptin in Diabetes Management: a Comprehensive Review.

• Authors : Pandya S; Department of Pharmaceutical Quality Assurance, School of Pharmacy, RK University, Bhavnagar Highway Kasturbadham, Rajkot-360020, Gujarat, India.; Vekaria HJ

Subjects: Metformin*/Metformin*/Metformin*/analysis ; Metformin*/Metformin*/Metformin*/therapeutic use ; Pioglitazone*/Pioglitazone*/Pioglitazone*/analysis

• Source: Journal of chromatographic science [J Chromatogr Sci] 2025 Feb 08; Vol. 63 (3).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0173225 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial.

• Authors : Kanimozhi M; MD Pharmacology Resident, All India Institute of Medical Sciences, Virbhadra Road, Rishikesh, Uttarakhand, India.; Bisht M

• Source: Perspectives in clinical research [Perspect Clin Res] 2025 Jan-Mar; Vol. 16 (1), pp. 14-22. Date of Electronic Publication: 2024 Jul 10.Publisher: Medknow Publications and Media Pvt. Ltd Country of Publication: India NLM ID: 101551517 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Stability-Indicating TLC-Densitometric and HPLC Methods for Simultaneous Determination of Teneligliptin and Pioglitazone in Pharmaceutical Dosage Forms with Eco-Friendly Assessment.

• Authors : Akabari AH; Department of Quality Assurance, Shree Naranjibhai Lalbhai Patel College of Pharmacy, Umrakh, Gujarat, India.; Gajiwala H

Subjects: Pioglitazone*/Pioglitazone*/Pioglitazone*/analysis ; Pioglitazone*/Pioglitazone*/Pioglitazone*/chemistry ; Thiazolidines*/Thiazolidines*/Thiazolidines*/analysis

• Source: Journal of chromatographic science [J Chromatogr Sci] 2025 Jan 14; Vol. 63 (2).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0173225 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

• Authors : Iijima H; Medical Affairs Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, 1-1-1, Marunouchi, Chiyoda-ku, Tokyo, 100-8205, Japan. .; Shimizu H

• Source: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Apr; Vol. 15 (4), pp. 763-777. Date of Electronic Publication: 2023 Dec Publisher: Springer Healthcare Country of Publication: United States NLM ID: 101539025 Publication Model: Print-Electronic Cited Medium: Print ISSN:

تفاصيل العنوان

Effect of glimepiride versus teneligliptin in combination with metformin in type 2 diabetes mellitus patients.

• Authors : Rasheed RA; Department of Pharmacology, Melmaruvathur Adhiparasakthi Institute of Medical Sciences and Research, Chengalpattu, Tamil Nadu, India.; Venkatraman G

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Metformin*/Metformin*/Metformin*/administration & dosage ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

• Source: Indian journal of pharmacology [Indian J Pharmacol] 2024 Sep 01; Vol. 56 (5), pp. 317-321. Date of Electronic Publication: 2024 Dec 16.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study.

• Authors : Isogawa M; Institute for Clinical and Translational Science, Nara Medical University Hospital, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan.; Makino H

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Thiazolidines*/Thiazolidines*/Thiazolidines*/therapeutic use

• Source: BMC endocrine disorders [BMC Endocr Disord] 2024 Aug 19; Vol. 24 (1), pp. 153. Date of Electronic Publication: 2024 Aug 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823

تفاصيل العنوان

Publisher Correction: Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model.

• Authors : Iijima H; Medical Affairs Department, Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, 1-1-1, Marunouchi, Chiyoda-ku, Tokyo, 100-8205, Japan. .; Shimizu H

• Source: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Apr; Vol. 15 (4), pp. 779-780.Publisher: Springer Healthcare Country of Publication: United States NLM ID: 101539025 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study.

• Authors : Kim HJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, San 5, Woncheon-dong, Yeongtong-gu, Suwon, 443-721, South Korea.; Kim YS

• Source: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2021 Nov; Vol. 12 (11), pp. 2907-2920. Date of Electronic Publication: 2021 Publisher: Springer Healthcare Country of Publication: United States NLM ID: 101539025 Publication Model: Print-Electronic Cited Medium: Print ISSN:

تفاصيل العنوان

No Significant Changes of Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Kidney Disease by Switching from Linagliptin to Teneligliptin.

• Authors : Hirai K; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.; Nonaka H

• Source: Pragmatic and observational research [Pragmat Obs Res] 2021 Aug 06; Vol. 12, pp. 81-91. Date of Electronic Publication: 2021 Aug 06 (Print Publication: 2021).Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101688693 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان

Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study).

• Authors : Bae JC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.; Kwak SH

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Blood Glucose*

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2022 Jan; Vol. 46 (1), pp. 81-92. Date of Electronic Publication: 2021 Jun 16.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان